- 2024-08-20 01:47抑制剂BMS-1001|BMS-1001|2113650-03-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:47抑制剂BMS 777607|BMS 777607|1025720-94-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:47抑制剂BMS 777607|BMS 777607|1025720-94-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:47抑制剂BMS 777607|BMS 777607|1025720-94-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:47抑制剂BMS-1001 hydrochloride|BMS-1001 hydrochloride|2113650-04-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:47抑制剂BMS 753|BMS 753|215307-86-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:47抑制剂BMS 753|BMS 753|215307-86-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:47抑制剂BMS 753|BMS 753|215307-86-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:47抑制剂BML-281|CAY10603|1045792-66-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:47抑制剂BML-281|CAY10603|1045792-66-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:47抑制剂BMP signaling agonist sb4|BMP signaling agonist sb4|100874-08-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:47抑制剂BMP signaling agonist sb4|BMP signaling agonist sb4|100874-08-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:47抑制剂Bis-PEG4-acid|Bis-PEG4-acid|31127-85-2|Adamas life|≥98%（以实测数值为准）|BR|250mg
- 2024-08-20 01:47抑制剂BMH-21|BMH-21|896705-16-1|Adamas life|≥97%（以实测数值为准）|BR|100mg
- 2024-08-20 01:47抑制剂BML-275|Dorsomorphin|866405-64-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:47抑制剂BML-281|CAY10603|1045792-66-2|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:47抑制剂BiP inducer X|BiP inducer X|101714-41-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:47抑制剂BiP inducer X|BiP inducer X|101714-41-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:47抑制剂BiP inducer X|BiP inducer X|101714-41-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:47抑制剂BI-D1870|BI-D1870|501437-28-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
